Valuation: Medpace Holdings, Inc.

Market Cap 18.82B 16.8B 15.46B 14.03B 26.59B 1,764B 27.25B 185B 73.71B 945B 70.65B 69.14B 2,975B P/E 2026 *
36.9x
P/E 2027 * 34.3x
Enterprise Value 18.01B 16.08B 14.79B 13.43B 25.45B 1,688B 26.08B 177B 70.54B 904B 67.6B 66.16B 2,847B EV / Sales 2026 *
6.32x
EV / Sales 2027 * 5.81x
Free-Float
81.14%
Yield 2026 *
-
Yield 2027 * -
1 day-1.01%
1 week+0.39%
Current month+2.16%
1 month+7.43%
3 months+10.57%
6 months+59.63%
Current year+18.60%
1 week 632.11
Extreme 632.11
679.18
1 month 605.76
Extreme 605.76
693.97
Current year 373
Extreme 373
693.97
1 year 373
Extreme 373
693.97
3 years 250.05
Extreme 250.05
693.97
5 years 126.94
Extreme 126.945
693.97
10 years 21.76
Extreme 21.76
693.97
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 65 01/09/2017
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Date Insider Type Main position Quantity % Market Cap. Importance
29/10/26 Sell

Compliance Officer

-1,245 0.0045%
27/10/26 Sell

Chief Operating Officer

-3,940 0.0141%
21/10/26 Exercice

Chief Operating Officer

5,400 0.0193%
Change 5-day change 1-year change 3-year change Capi.($)
-1.01%+0.39%+10.94%+141.91% 18.82B
+0.01%+8.40%+58.48%+69.01% 68.22B
+1.97%+10.37%+16.83%+91.64% 59.82B
-0.21%+1.01%+23.37%+96.89% 56.07B
+0.74%+18.25%+27.52%+110.83% 47.67B
-1.23%+4.91%+29.31%+40.57% 45.95B
-1.83%+1.43%+214.04%+899.49% 43.29B
-3.33%+5.73%+23.28%+47.32% 35.66B
-0.45%-2.29%+93.76%+68.79% 34.73B
+2.02%+12.71%-38.67%+395.62% 25.47B
Average -0.32%+5.19%+45.89%+196.21% 44B
Weighted average by Cap. -0.21%+5.34%+49.43%+180.24%

Financials

2026 *2027 *
Net sales 2.85B 2.54B 2.34B 2.12B 4.03B 267B 4.13B 28B 11.16B 143B 10.7B 10.47B 450B 3.02B 2.7B 2.48B 2.25B 4.27B 283B 4.37B 29.69B 11.83B 152B 11.34B 11.1B 478B
Net income 521M 465M 428M 388M 735M 48.79B 754M 5.11B 2.04B 26.12B 1.95B 1.91B 82.27B 554M 494M 455M 413M 782M 51.91B 802M 5.44B 2.17B 27.79B 2.08B 2.03B 87.52B
Net Debt -812M -725M -667M -605M -1.15B -76.08B -1.18B -7.98B -3.18B -40.73B -3.05B -2.98B -128B -1.27B -1.14B -1.04B -948M -1.8B -119B -1.84B -12.5B -4.98B -63.84B -4.78B -4.67B -201B
Projected Income Statement - Annual - Medpace Holdings, Inc.
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,600
Date Price Change Volume
10/11/26 $666.11 -1.01% 14,509
09/11/26 $672.93 +3.03% 219,169
06/11/26 $653.11 +2.86% 231,625
05/11/26 $634.98 -3.32% 315,868
04/11/26 $656.77 -1.01% 232,664
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Medpace Holdings, Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
672.93USD
Average target price
651.31USD
Spread / Average Target
-3.21%
  1. Stock Market
  2. Stocks
  3. MEDP Stock